Skip to main content
. 2019 Jan 28;2019(1):CD008940. doi: 10.1002/14651858.CD008940.pub3

Summary of findings 3. Mixed action antidepressant compared to placebo for cannabis dependence.

Mixed action antidepressant compared to placebo for cannabis dependence
Patient or population: cannabis dependence
 Setting: outpatient
 Intervention: mixed action antidepressant
 Comparison: placebo
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Certainty of the evidence
 (GRADE)
Risk with placebo Risk with mixed action antidepressant
Participants abstinent at end of treatment Study population RR 0.82
(0.12 to 5.41)
179
 (2 RCTs) ⊕⊕⊝⊝
 Lowa,b
250 per 1000 205 per 1000
 (30 to 1000)
Participants experiencing adverse effects Study population RR 0.93
(0.55 to 1.55)
76
 (1 RCT) ⊕⊕⊝⊝
 Lowc
450 per 1000 419 per 1000
 (248 to 698)
Participants withdrawn due to adverse effects Study population RR 1.44
(0.11 to 18.90)
179
 (2 RCTs) ⊕⊕⊝⊝
 Lowa,b
11 per 1000 16 per 1000
 (1 to 205)
Completion of scheduled treatment Study population RR 0.93
(0.71 to 1.21)
169
 (2 RCTs) ⊕⊕⊝⊝
 Lowc
573 per 1000 533 per 1000
 (407 to 694)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
 Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
 Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
 Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

aDowngraded one level for inconsistency: significant heterogeneity between studies.

bDowngraded one level for imprecision: very few events and small group sizes.

cDowngraded two levels for imprecision: very few events and small group sizes.

cStudies differed in direction of effect without significant heterogeneity.